Dual inhibition of CB 1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID‐19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual inhibition of CB
1
receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID‐19
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-03-26
DOI
10.1111/bph.15461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The therapeutic potential of second and third generation CB1R antagonists
- (2020) Resat Cinar et al. PHARMACOLOGY & THERAPEUTICS
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
- (2020) Tomasz J Guzik et al. CARDIOVASCULAR RESEARCH
- Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
- (2020) Zheng Ye et al. EUROPEAN RADIOLOGY
- Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
- (2020) Francesca Rossi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
- (2020) Christopher M Petrilli et al. BMJ-British Medical Journal
- Pulmonary fibrosis secondary to COVID-19: a call to arms?
- (2020) Paolo Spagnolo et al. Lancet Respiratory Medicine
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
- (2020) Peter M George et al. Lancet Respiratory Medicine
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Admission hyperglycemiaas a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry
- (2020) Francisco Javier Carrasco-Sánchez et al. ANNALS OF MEDICINE
- Post-COVID-19 pneumonia pulmonary fibrosis
- (2020) S Tale et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Novel insight from the first lung transplant of a COVID‐19 patient
- (2020) Xiao‐Jun Chen et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection
- (2020) Niyati Desai et al. Nature Communications
- Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis
- (2018) Preeti Singh et al. Pharmacological Reports
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of iNOS on Immune Cells and Its Role in Diseases
- (2018) Qingjie Xue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4
- (2018) Bruno Galvão-Filho et al. Mucosal Immunology
- Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages
- (2017) Inigo Ruiz de Azua et al. JOURNAL OF CLINICAL INVESTIGATION
- Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD
- (2017) Shiran Udi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
- (2017) Pal Pacher et al. Nature Reviews Cardiology
- Lung exposure to lipopolysaccharide causes atherosclerotic plaque destabilisation
- (2016) Jen Erh Jaw et al. EUROPEAN RESPIRATORY JOURNAL
- The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide-induced lung inflammation
- (2015) Arnold Johnson et al. JOURNAL OF NEUROIMMUNOLOGY
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents
- (2014) M. Shahidi et al. JOURNAL OF GENERAL VIROLOGY
- Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
- (2014) Tony Jourdan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
- (2012) M. Rajesh et al. DIABETES
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatitis C Virus Induces the Cannabinoid Receptor 1
- (2010) David van der Poorten et al. PLoS One
- Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury
- (2009) Suzanne Heemskerk et al. Nature Reviews Nephrology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now